- On Thursday $4 announced CEO Terry Booth is $4.
- Shares fell as much as 19% Friday.
- Here's what four Wall Street analysts are saying about the Canadian cannabis company.
- $4.
- $4.
Shares of Aurora Cannabis tumbled as much as 19% Friday after the company $4 Thursday that its $4.
The decision to cut the full-time roles, including 25% of corporate positions, was an "incredibly difficult" one that was "not taken lightly," said Glen Ibbott, Aurora's chief financial officer, on a Thursday call with analysts and investors.
Aurora's executive chairman, Michael Singer, will take over as the interim CEO while the company board searches for a full-time replacement. Aurora's banking syndicate $4, and the company will $4 related to assets the company acquired in Denmark and South America.
The company also announced preliminary results for the quarter that ended December 31 that fell short of Wall Street's expectations. The company said it expects cannabis revenue between C$50 million and C$54 million, where analysts were expecting $79 million, $4.
The slump is the latest setback for the beleaguered stock, which has struggled to gain in 2020 as turmoil continues to hit the cannabis industry. Shares of other cannabis companies also took a hit - $4 sank 5%, $4 fell 7%, and $4 traded 4% lower Friday afternoon in New York.
Aurora Cannabis has a consensus price target of $2.52 and six "buy" ratings, 11 "hold" ratings, and five "sell" ratings, according to Bloomberg data.
Here's what four analysts are saying about Aurora Cannabis, ranked in order of highest to lowest price target: